Genmab | Rörelseresultat



Operating Profit Ändra Datum
Agios Pharmaceuticals USD -125037000 1.11B 2024-12
Almirall EUR 53.03M 68.53M 2024-06
Amarin USD -25168000 24.64M 2024-09
Amgen USD 2.31B 182M 2024-12
argenx SE USD 103.04M 86.87M 2024-12
AstraZeneca USD 2.04B 731M 2024-12
Bayer EUR 3.53B 7.35B 2024-12
BioMarin Pharmaceutical USD 161.41M 47.51M 2024-12
Demant DKK 2.34B 1.32B 2024-12
Exelixis USD 163.21M 27.13M 2025-01
Fresenius Medical Care EUR 258.9M 204.1M 2024-12
Galapagos EUR -158708000 95.99M 2025-03
Genmab DKK 2.19B 89M 2024-12
GlaxoSmithKline GBP 696M 507M 2024-12
GN Store Nord DKK 701M 242M 2024-12
GRIFOLS EUR 371.86M 54.83M 2024-12
Hikma Pharmaceutical USD 327M 208M 2024-06
Insmed USD -230414000 16.98M 2024-12
Lonza CHF 534M 194M 2024-06
Merck EUR 1.2B 100M 2024-12
Novartis USD 2.28B 1.34B 2024-12
Regeneron Pharmaceuticals USD 990.2M 189.3M 2024-12
Roche Holding CHF 4.39B 1.04B 2024-12
Sanofi EUR 2.28B 1.42B 2025-03
UCB EUR 163M 39M 2024-06



Genmab Rörelseresultat - Aktuella värden, historiska data, prognoser, statistik, diagram och ekonomisk kalender - Apr 2025.